← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2003Last known activity
Aug 4, 2025
Timeline
1900s
- Jan 1, 1906
Institute of Tropical Medicine, Belgium— Founded
Drugs by trial phase (57 distinct, 48 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (29 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Bacterial Infections
- Communicable Diseases
- Fetal Growth Retardation
- Gram-Positive Bacterial Infections
- HIV Infections
- HIV Seropositivity
- Immune Reconstitution Inflammatory Syndrome
- Infections
- Leishmaniasis
- Leishmaniasis, Visceral
- Leprosy
- Malaria
- Malaria, Falciparum
- Mycobacterium Infections
- Parasitemia
- Parasitic Diseases
- Protozoan Infections
- Rabies
- Recurrence
- Schistosomiasis
- Syndrome
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
Recent trials (50)
- NCT06839989Lead sponsorPhase 2Aug 4, 2025
- NCT06839989OfficialPhase 2Aug 4, 2025
- NCT06356974OfficialPhase 3Apr 8, 2024
- NCT06356974CollaboratorPhase 3Apr 8, 2024
- NCT06126822OfficialPhase 3Mar 31, 2024
- NCT06126822Overall official - principal investigatorPhase 3Mar 31, 2024
- NCT06126822Lead sponsorPhase 3Mar 31, 2024
- NCT05597280Lead sponsorPhase 3Mar 1, 2023
- NCT05555303CollaboratorPhase 2Dec 31, 2022
- NCT05406479Lead sponsorPhase 2Jul 14, 2022
- NCT05119426CollaboratorPhase 4Jan 31, 2022
- NCT05027516Lead sponsorPhase 4Sep 30, 2021
- NCT04310085CollaboratorPhase 1Mar 18, 2020
- NCT03893097Lead sponsorPhase 3Oct 14, 2019
- NCT03862248Lead sponsorPhase 3Sep 30, 2019
Details
- Founded
- Brussels, BE Jan 1, 1906
- Last known activity
- Aug 4, 2025